Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing ∇

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 1107-1118

  Monleau, Marjorie ^a   Montavon, Céline ^a   Laurent, Christian ^a   Segondy, Michel ^b   Montes, Brigitte ^b   Delaporte, Eric ^a   Boillot, François ^c,d   Peeters, Martine ^a,e  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c Alter Santé Internationale and Développement   (France)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NUCLEIC ACID; VIRUS RNA;

ARTICLE; ASSAY; BLOOD; BLOOD SAMPLING; DIAGNOSTIC TEST; EXTRACTION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; NONHUMAN; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; ANALYTICAL EQUIPMENT; ANTIVIRAL RESISTANCE; COMPARATIVE STUDY; DESICCATION; DIAGNOSTIC PROCEDURE; EVALUATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; METHODOLOGY; TEMPERATURE; TIME; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

BLOOD; DESICCATION; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PLASMA; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS; VIRAL LOAD;

EID: 65249136428     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02255-08     Document Type: Article

References (26)

1. Alvarez-Munoz, M. T., S. Zaragoza-Rodriguez, O. Rojas-Montes, G. Palacios-Saucedo, G. Vazquez-Rosales, A. Gomez-Delgado, J. Torres, and O. Munoz. 2005. High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions. Arch. Med. Res. 36:382-386.
2. Amellal, B., C. Katlama, and V. Calvez. 2007. Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification. HIV Med. 8:396-400.
3. Ayele, W., R. Schuurman, T. Messele, W. Dorigo-Zetsma, Y. Mengistu, J. Goudsmit, W. A. Paxton, M. P. de Baar, and G. Pollakis. 2007. Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden. J. Clin. Microbiol. 45:891-896.
4. Barin, F., L. Meyer, R. Lancar, C. Deveau, M. Gharib, A. Laporte, J. C. Desenclos, and D. Costagliola. 2005. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J. Clin. Microbiol. 43: 4441-4447.
5. Bertagnolio, S., I. Derdelinckx, M. Parker, J. Fitzgibbon, H. Fleury, M. Peeters, R. Schuurman, D. Pillay, L. Morris, A. Tanuri, G. M. GershyDamet, J. Nkengasong, C. F. Gilks, D. Sutherland, and P. Sandstrom. 2008. World Health Organization/HIVResNet drug resistance laboratory strategy. Antivir. Ther. 13 (Suppl. 2) :49-57.
6. Bertagnolio, S., L. Soto-Ramirez, R. Pilon, R. Rodriguez, M. Viveros, L. Fuentes, P. R. Harrigan, T. Mo, D. Sutherland, and P. Sandstrom. 2007. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther. 12:107-113.
7. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
8. Boillot, F., M. Peeters, A. Kosia, and E. Delaporte. 1997. Prevalence of the human immunodeficiency virus among patients with tuberculosis in Sierra Leone, established from dried blood spots on filter paper. Int. J. Tuberc. Lung Dis. 1:493-497.
9. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
10. Brambilla, D., C. Jennings, G. Aldrovandi, J. Bremer, A. M. Comeau, S. A. Cassol, R. Dickover, J. B. Jackson, J. Pitt, J. L. Sullivan, A. Butcher, L. Grosso, P. Reichelderfer, and S. A. Fiscus. 2003. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J. Clin. Microbiol. 41:1888-1893.
11. Cassol, S., M. J. Gill, R. Pilon, M. Cormier, R. F. Voigt, B. Willoughby, and J. Forbes. 1997. Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. J. Clin. Microbiol. 35:2795-2801.
12. Dachraoui, R., D. Brand, S. Brunet, F. Barin, and J. C. Plantier. 2008. RNA amplification of the HIV-1 Pol and Env regions on dried serum and plasma spots. HIV Med. 9:557-561.
13. Gilks, C. F., S. Crowley, R. Ekpini, S. Gove, J. Perriens, Y. Souteyrand, D. Sutherland, M. Vitoria, T. Guerma, and K. De Cock. 2006. The WHO public-health approach to antiretroviral treatment against HIV in resourcelimited settings. Lancet 368:505-510.
14. Hallack, R., L. E. Doherty, J. A. Wethers, and M. M. Parker. 2008. Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene ((R)) HIV-1 genotyping assay. J. Clin. Virol. 41:283-287.
15. Kane, C. T., H. D. Ndiaye, S. Diallo, I. Ndiaye, A. S. Wade, P. A. Diaw, A. Gaye-Diallo, and S. Mboup. 2008. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal. J. Virol. Methods 148:291-295.
16. Masciotra, S., C. Garrido, A. S. Youngpairoj, A. McNulty, N. Zahonero, A. Corral, W. Heneine, C. de Mendoza, and J. G. Garcia-Lerma. 2007. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. AIDS 21:2503-2511.
17. McNulty, A., C. Jennings, D. Bennett, J. Fitzgibbon, J. W. Bremer, M. Ussery, M. L. Kalish, W. Heneine, and J. G. Garcia-Lerma. 2007. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J. Clin. Microbiol. 45:517-521.
18. Mwaba, P., S. Cassol, R. Pilon, C. Chintu, M. Janes, A. Nunn, and A. Zumla. 2003. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients. Lancet 362:1459-1460.
19. Plantier, J. C., R. Dachraoui, V. Lemee, M. Gueudin, F. Borsa-Lebas, F. Caron, and F. Simon. 2005. HIV-1 resistance genotyping on dried serum spots. AIDS 19:391-397.
20. Rouet, F., M. L. Chaix, E. Nerrienet, N. Ngo-Giang-Huong, J. C. Plantier, M. Burgard, M. Peeters, F. Damond, D. K. Ekouevi, P. Msellati, L. Ferradini, S. Rukobo, V. Marechal, N. Schvachsa, L. Wakrim, C. Rafalimanana, B. Rakotoambinina, J. P. Viard, J. M. Seigneurin, and C. Rouzioux. 2007. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA secondgeneration long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J. Acquir. Immune Defic. Syndr. 45:380-388.
21. Rouet, F., D. K. Ekouevi, M. L. Chaix, M. Burgard, A. Inwoley, T. D. Tony, C. Danel, X. Anglaret, V. Leroy, P. Msellati, F. Dabis, and C. Rouzioux. 2005. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J. Clin. Microbiol. 43:2709-2717.
22. Solomon, S. S., S. Pulimi, I. I. Rodriguez, S. K. Chaguturu, S. K. Satish Kumar, K. H. Mayer, and S. Solomon. 2004. Dried blood spots are an acceptable and useful HIV surveillance tool in a remote developing world setting. Int. J. STD AIDS 15:658-661.
23. Waters, L., A. Kambugu, H. Tibenderana, D. Meya, L. John, S. Mandalia, M. Nabankema, I. Namugga, T. C. Quinn, B. Gazzard, S. J. Reynolds, and M. Nelson. 2007. Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J. Acquir. Immune Defic. Syndr. 46:590-593.
24. WHO. 2006. HIV/AIDS programme. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. WHO, Geneva, Switzerland. www.who.int/hiv/pub/guidelines/adult /en/index.html.
25. Youngpairoj, A. S., S. Masciotra, C. Garrido, N. Zahonero, C. de Mendoza, and J. G. Garcia-Lerma. 2008. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4°C. J. Antimicrob. Chemother. 61:12171220.
26. Ziemniak, C., A. George-Agwu, W. J. Moss, S. C. Ray, and D. Persaud. 2006. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J. Virol. Methods 136:238-247.